Comparison of [177Lu-DOTA0,Tyr3]-Octreotate and [177Lu-DOTA0,Tyr3]-Octreotide for Receptor-Mediated Radiation Therapy of the Xenografted Human Midgut Carcinoid Tumor GOT1-Reference-Cited by-同舟云学术

Comparison of [177Lu-DOTA0,Tyr3]-Octreotate and [177Lu-DOTA0,Tyr3]-Octreotide for Receptor-Mediated Radiation Therapy of the Xenografted Human Midgut Carcinoid Tumor GOT1

Published:2008-02 Issue:1 Volume:23 Page:114-120
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Swärd Christina¹²,Bernhardt Peter³,Johanson Viktor¹²,Schmitt Anneli³,Ahlman Håkan¹²,Stridsberg Mats⁴,Forssell-Aronsson Eva³,Nilsson Ola¹⁵,Kölby Lars¹²

Affiliation:

1. The Lundberg Laboratory for Cancer Research, Sahlgrenska University Hospital, Göteborg, Sweden

2. Department of Surgery, Sahlgrenska University Hospital, Göteborg, Sweden

3. Department of Radiation Physics, Sahlgrenska University Hospital, Göteborg, Sweden

4. Department of Medical Sciences, Clinical Chemistry, University Hospital, Uppsala, Sweden

5. Department of Pathology, Sahlgrenska University Hospital, Göteborg, Sweden

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2007.0421

Reference27 articles.

1. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours

2. Rationale for the use of somatostatin analogs as antitumor agents

3. Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of 177Lu-octreotate and 177Lu-octreotide for treatment in human neuroblastoma-bearing mice;Heliyon;2024-05

2. Potent candidates for Targeted Auger Therapy: Production and radiochemical considerations;Nuclear Medicine and Biology;2021-03

3. Design, preparation and biological evaluation of a 177Lu-labeled somatostatin receptor antagonist for targeted therapy of neuroendocrine tumors;Bioorganic Chemistry;2020-01

4. 177Lu-octreotate therapy for neuroendocrine tumours is enhanced by Hsp90 inhibition;Endocrine-Related Cancer;2019-04

5. Molecular Imaging Companion Diagnostics;Companion and Complementary Diagnostics;2019